EDGAR·FLOW

CHINA PHARMA HOLDINGS, INC. — Form 10-Q

Filed November 18, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 18/100
What the filing says
Zhilin Li, as both CEO and interim CFO, certified the Form 10-Q for the quarter ended September 30, 2026 (filed November 18, 2026). The certification confirms financial statements fairly present the company's condition and operations, with established disclosure controls and internal reporting procedures. No specific financial results, transactions, or material changes are disclosed in these certification exhibits alone.
Why this rating

Routine SOX 302/906 officer certifications; no operational, financial, or transactional data disclosed. Standard compliance filing for micro-cap.

View original filing on SEC.gov ↗ CPHI · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.